tiprankstipranks
Trending News
More News >
Cognition Therapeutics (CGTX)
NASDAQ:CGTX
US Market

Cognition Therapeutics (CGTX) Income Statement

Compare
298 Followers

Cognition Therapeutics Income Statement

Last quarter (Q4 2024), Cognition Therapeutics's total revenue was $0.00, a decrease of -100.00% from the same quarter last year. In Q4, Cognition Therapeutics's net income was $-7.84M. See Cognition Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ -252.00K$ -235.00K$ -93.00K$ -98.00K
Operating Expenses
$ 53.97M$ 50.72M$ 21.33M$ 11.15M$ 6.55M
Depreciation and Amortization
$ 0.00$ 252.00K$ 235.00K$ 93.00K$ 98.00K
EBITDA
$ -53.97M$ -25.51M$ -21.13M$ -13.38M$ -5.99M
Operating Income
$ -53.97M$ -50.72M$ -43.55M$ -28.60M$ -17.41M
Other Income/Expenses
$ 20.00M$ 24.94M$ 22.15M$ 16.88M$ 9.57M
Pretax Income
$ -33.97M$ -25.79M$ -21.40M$ -11.72M$ -7.84M
Net Income
$ -33.97M$ -25.79M$ 757.00K$ -10.29M$ -10.07M
Per Share Metrics
Basic EPS
$ -0.86$ -0.86$ 0.03$ -0.46$ -0.46
Diluted EPS
$ -0.86$ -0.86$ 0.03$ -0.46$ -0.46
Weighted Average Shares Outstanding
39.73M 29.99M 28.99M 22.23M 21.94M
Weighted Average Shares Outstanding (Diluted)
39.73M 30.03M 28.99M 22.23M 21.94M
Currency in USD

Cognition Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis